← Back
$VRTX All transactions

VERTEX PHARMACEUTICALS INC / MA

A

$ Value

$0

Shares

37,622

Price

$0

Filed

May 15

Insider

Name

Arbuckle Stuart A

Title

EVP, COO

CIK

0001557290

Roles

Officer

Transaction Details

Transaction Date

2025-05-13

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

100,611

Footnotes

Represents earned performance shares with respect to a performance stock unit award granted on 12/06/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 05/13/2025 and the shares will vest on 07/01/2025.

Filing Info

Accession No.

0000875320-25-000196

Form Type

4

Issuer CIK

0000875320

Arbuckle Stuart A's History

Date Ticker Type Value
2026-02-06 PRAX A $0
2026-02-06 PRAX A $0
2026-02-06 PRAX A $0
2026-01-05 ALNY A $0
2025-07-01 VRTX F $16.8M
2025-06-24 RYTM A $0
2025-06-24 RYTM A $0
2025-06-18 RYTM M
2025-06-18 RYTM M $0
2025-05-13 VRTX A $0

Other Insiders at VRTX (90d)

Insider Bought Sold Last
SACHS BRUCE I 2026-04-15
WAGNER CHARLES F JR
EVP, CO & FO
2026-01-22
LEIDEN JEFFREY M
Executive Chairman
2026-01-22
Garber Alan M 2026-04-15
Sachdev Amit
EVP Chief Patient & Ext Af Off
2026-01-22
Upadhyay Suketu 2026-04-15
ALTSHULER DAVID
EVP, Chief Scientific Officer
2026-01-22
Kewalramani Reshma
CEO & President
2026-01-22
Biller Jonathan
EVP and Chief Legal Officer
$886K 2026-02-11
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
2026-01-22
Bozic Carmen
EVP and CMO
$1.1M 2026-03-27
Liu Joy
EVP and Chief Legal Officer
$439K 2026-04-01
Ambrose Kristen
SVP & Chief Accounting Officer
$634K 2026-02-11
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
$806K 2026-02-11
McKechnie Duncan
EVP, Chief Commercial Officer
2026-01-22
Bunnage Mark E.
EVP, Chief Scientific Officer
$931K 2026-02-11